AI Summary Deferiprone (Ferriprox) is an oral iron chelator used for transfusional iron overload when other chelators are insufficient or not tolerated.
Medically reviewed.
Deferiprone (brand name Ferriprox) is an oral iron chelator used mainly for transfusional iron overload when other iron chelators are insufficient, not tolerated, or need to be combined with additional therapy. It works by binding excess iron in the blood and tissues and helping the body remove it, mainly through urinary excretion, which helps reduce iron-related damage to the liver and heart. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers deferiprone's role in iron overload management — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether deferiprone fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT DEFERIPRONE TREATMENT
Deferiprone is a prescription medicine sold under the brand name Ferriprox. It belongs to a class of medications called iron chelators.
Deferiprone is used mainly to treat transfusional iron overload — iron buildup caused by repeated blood transfusions — when other iron chelators, such as deferasirox or deferoxamine, have not worked well enough or are not tolerated. It may also be used in combination with another chelator for resistant, chronic iron overload, including some cases linked to hereditary hemochromatosis.
Deferiprone works by binding excess iron circulating in the blood and stored in tissues, forming complexes that the body removes mainly through the urine. This helps reduce iron accumulation in the heart and liver and helps prevent iron-related organ damage.
Deferiprone is typically used alongside frequent monitoring by your healthcare provider, including absolute neutrophil count (ANC), liver function tests, and ferritin levels.
WHO DEFERIPRONE MAY BE SUITABLE FOR
Eligibility for deferiprone depends on your diagnosis, iron levels, and how you have responded to other treatments. Your healthcare provider may consider deferiprone if you have transfusional iron overload, an inadequate response to other iron chelators, cannot tolerate alternative iron removal therapies, need combination iron chelation therapy, or require ongoing management of chronic iron overload.
Because deferiprone carries a risk of neutropenia and agranulocytosis, your provider will weigh this risk against the benefits of iron removal and will typically arrange regular blood count monitoring before and during treatment.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take deferiprone. Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your iron levels, liver condition, and treatment goals.
ELIGIBILITY OVERVIEW
Deferiprone may be considered for adults with the following conditions, risk factors, or treatment goals:
Before recommending deferiprone, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW DEFERIPRONE CAN HELP YOUR LIVER
Deferiprone binds excess iron that is circulating in the blood and stored in tissues, including the liver and heart. Once bound, the iron-deferiprone complex is removed from the body mainly through urinary excretion.
By lowering the amount of excess iron in circulation and in organs, deferiprone helps reduce iron accumulation in the heart and liver and helps prevent the organ damage that chronic iron overload can cause. It can be used alone or combined with another iron chelator in cases where iron overload is difficult to control.
For patients with transfusional iron overload, these effects can support treatment goals such as lower ferritin levels, reduced iron deposition in the heart and liver, and a lower risk of iron-related organ damage over time. Deferiprone requires close, ongoing monitoring — providers regularly check absolute neutrophil count (ANC), liver function, and ferritin levels to track response and safety.
LIVER BENEFITS
Deferiprone binds excess iron held in tissues, including the liver, so the body can clear it. This helps reduce iron accumulation in the liver.
Iron that builds up over time can injure organs. By lowering the iron load, deferiprone helps prevent this kind of damage.
Your provider checks liver function and ferritin levels often during treatment. Elevated liver enzymes are a known side effect, so these tests help catch changes early.
Deferiprone is used as long-term therapy for chronic iron overload. Your provider adjusts treatment over time based on ferritin trends and your iron burden.
Deferiprone helps lower iron in the liver and protect against iron-related organ damage. It requires frequent blood monitoring and should only be started and managed under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Deferiprone is available as oral tablets or an oral solution. Take it exactly as prescribed, and check with your pharmacist about your specific formulation and strength.
The typical dose is about 75 mg/kg/day, divided into two or three doses, adjusted based on your response and tolerance. Your healthcare provider determines the right dose for you.
Deferiprone is taken orally multiple times a day, with or without food. Always use it exactly as your healthcare provider directs.
Deferiprone is used as long-term therapy. Duration is determined by ongoing transfusional iron burden and ferritin trends, and treatment may continue indefinitely while it continues to provide benefit.
Store deferiprone at room temperature, away from moisture and heat.
Frequent monitoring of absolute neutrophil count (ANC), liver function, and ferritin levels is required throughout treatment to check for benefit and catch safety issues early.
BENEFITS AND SAFETY
Deferiprone may support people with transfusional iron overload by binding excess iron in the blood and tissues and helping the body remove it, mainly through urinary excretion. This can help reduce iron accumulation in the heart and liver and help protect against iron-related organ damage. It can be used alone or in combination with another iron chelator in resistant cases. The extent of these benefits varies from person to person, depending on the degree of iron overload, response to prior therapies, and how the body tolerates treatment. Deferiprone works best as part of a broader care plan that includes limiting excess dietary iron, moderating alcohol intake, and frequent blood monitoring.
As with any medication, deferiprone may cause side effects, ranging from nausea, abdominal pain, and joint pain to elevated liver enzymes. Deferiprone also carries a serious risk of neutropenia or agranulocytosis — a sharp drop in a type of white blood cell that fights infection — so your healthcare provider will require frequent blood count monitoring throughout treatment and will assess whether deferiprone remains a suitable option for you.
BENEFITS
Deferiprone binds excess iron circulating in the blood and stored in tissues, promoting its removal mainly through the urine.
By lowering iron accumulation in the heart, deferiprone helps reduce the risk of iron-related heart damage, a leading concern in chronic iron overload.
As an oral tablet or solution, deferiprone offers a convenient, non-infusion option for people who need ongoing iron chelation.
Deferiprone can be combined with other iron chelators in cases where iron overload has not responded adequately to a single agent.
Neutropenia and agranulocytosis are serious risks that require frequent blood count monitoring throughout treatment. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including scheduled blood tests, to ensure safe use.
SUPPORTING YOUR RESULTS
Lifestyle habits are an important part of a comprehensive treatment plan alongside deferiprone. Because deferiprone requires frequent blood monitoring for safety, staying consistent with lab visits is just as important as taking the medication as prescribed.
These habits can support how your body responds to treatment and may help your healthcare provider catch potential issues, such as low neutrophil counts, before they become serious.
Areas that may support treatment:
common questions
No, deferiprone is not a cure. It is a chelation therapy that binds excess iron and helps the body remove it, which can reduce iron accumulation in the heart and liver over time. It does not address the underlying cause of iron overload, and ongoing treatment and monitoring are typically needed. Talk with your healthcare provider about realistic goals for your treatment plan.
Deferiprone may not be appropriate for people with a history of neutropenia or agranulocytosis, or those unable to commit to frequent blood count monitoring, since this monitoring is essential for detecting serious blood-related side effects early. Your healthcare provider will review your medical history and current health status to determine whether deferiprone is safe for you.
The most serious risk of deferiprone (Ferriprox) is neutropenia or agranulocytosis, a sharp drop in the white blood cells that fight infection. This can leave you vulnerable to serious infections, so your healthcare provider requires frequent blood count monitoring throughout treatment. Watch for signs such as fever, sore throat, or mouth sores, and report them right away. Discuss this risk with your healthcare provider before starting treatment so you understand what to watch for.
Your healthcare provider tracks how well deferiprone is working through regular blood tests, including ferritin levels, which reflect your body's iron stores over time. Falling ferritin trends generally suggest the medication is helping remove excess iron, while liver function and absolute neutrophil count are checked to monitor safety. Because response varies by person, only your healthcare provider can interpret your results and adjust your treatment plan accordingly.
Deferiprone, deferasirox, and deferoxamine are all iron chelators, but they differ in how they are taken and when they are used. Deferiprone and deferasirox are oral medications, while deferoxamine is given by injection or infusion. Deferiprone is often considered when other chelators have not worked well enough or are not tolerated, and it can also be combined with another chelator in resistant cases. Your healthcare provider will recommend the option that best fits your iron levels, health history, and treatment response.
Deferiprone requires frequent monitoring of absolute neutrophil count (ANC), liver function, and ferritin levels. This frequent blood count monitoring is essential because deferiprone carries a risk of neutropenia or agranulocytosis, a serious drop in infection-fighting white blood cells. Your healthcare provider will set a monitoring schedule and explain what to watch for between visits.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
